CClinicalTrials.gg
RecruitingNCT04137237HaWPYCUpdated Sep 16, 2025

Hand & Wrist Pyrocarbon Implants Outcomes Clinical Study

An observational study in Orthopedics, sponsored by Stryker Trauma and Extremities. Recruiting at 4 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-16.

Sponsored by Stryker Trauma and Extremities · Observational

From the registry’s dates

  • Started Nov 2019; still recruiting 6 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
417
Ages
18 Years and older
Sex
All
01

Study summary

HaWPYC is an international Post-Market Clinical Follow-up (PMCF) to collect post-market safety and performance data on commercially available Pyrocarbon (PyC) hand and wrist implants used in this study. Data may be used for Post-Market Surveillance, and regulatory requirements.

Read the detailed description

The objective of this multicenter study is to collect preoperative, intraoperative, intermediate (approx. 2 years), mid-term (approx. 5 years), and long-term (approx. 10 years) postoperative data, on related clinical complications and clinical outcomes on the Sponsors market-approved hand and wrist Pyrocarbon implants, to demonstrate safety and performance of these implants in a real-world setting.

02

Conditions studied

  • Orthopedics

Keywords

  • Hand
  • Wrist
  • Surgery
03

In context

Lead sponsor

Stryker Trauma and Extremities is the lead sponsor of 43 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

417 patients will be enrolled (About 50 to 80 per implant type). Prospective patients: screening and surgery should occur after the First site initiation visit.

"Ambispective" patients:

  • Screening and surgery occurred before the date of the first site initiation visit,
  • Follow-up visits (at least the last two) must be prospective (i.e: must occur after the date of the first site initiation visit),
  • Inclusions of consecutive patients,
  • Minimum available data must be available for each completed visit.

Inclusion criteria

  • 18 years or older at the time he/she receives the information and signs the informed consent (when applicable as per local regulatory requirements),
  • Informed on the study and willing to sign an informed consent form approved by Institutional Review Board or Ethics Committee,
  • Willing and able to comply with the requirements of the study protocol,
  • For prospective inclusion: considered for treatment with one of PyC Hand/Wrist study implants (primary or revision surgery),
  • For "ambispective" inclusion: must have undergone a Hand or Wrist arthroplasty with a PyC Hand/Wrist study implant before the date of first site initiation visit,

    • Follow-up visits (at least the last two) must be prospective,
    • Patient must have complete information available for each completed visit

Exclusion criteria

Exclusion Criteria:

  • Patient pertaining to one of the categories referred to as "vulnerable population" in the French Law (articles L. 1121-5 to L. 1121-8 of the French Public Health Code), or as "particularly vulnerable persons" in the Swiss Federal Law (Chapter 3, Sections 1 to 4 of CC 810.30 Federal Act on Research involving Human Beings - Human Research Act, HRA),
  • Patient unable to comply with the study procedures based on the judgment of the investigator (e.g. cannot comprehend study questions, inability to keep scheduled assessment times),
  • Any medical condition that could impact on the study outcomes functional signification at the investigator's discretion (e.g., neuropathy, allergy…)
05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
417 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Total QuickDASH average compared to the predefined Minimal Clinically Important Difference (MCID)

    Demonstrate a superior (lower) total QuickDASH average by 24 months postoperatively compared to the predefined Minimal Clinically Important Difference (MCID) upper threshold of 36 points. QuickDash = Disabilities of the Arm, Shoulder and Hand), self-report questionnaire; 11 items to measure physical function and symptoms; items scored on a 1-5-point scale which is then transformed resulting in a score from 0 (least disability) to 100 (most disability).

    Time frame: 24 months

Secondary outcomes

  1. Change from baseline in Patient Satisfaction scores

    Single, subjective question measuring patient satisfaction; assessed through 4 levels satisfaction: "Very Satisfied, Satisfied, Dissatisfied, and Very Dissatisfied".

    Time frame: up to 10 years

  2. Safety evaluation

    Number of device associated and procedure associated adverse events

    Time frame: up to 10 years

  3. Implant Survivorship

    Rates of revision surgeries; assessed using the Kaplan-Meyer analysis

    Time frame: up to 10 years

  4. Clinical assessment: change from baseline in QuickDash score

    QuickDash = Disabilities of the Arm, Shoulder and Hand), self-report questionnaire; 11 items to measure physical function and symptoms; items scored on a 1-5-point scale which is then transformed resulting in a score from 0 (least disability) to 100 (most disability).

    Time frame: up to 10 years

  5. Clinical assessment: change from baseline in PRWE score

    PRWE = Patient-rated Wrist Evaluation; patient reported outcome developed to assess pain in the wrist joint and functional difficulties in activities of daily living resulting from injuries affecting wrist joint area. 15-item questionnaire made of two subscales (pain and function), resulting in a score from 0 to 100; Less score = better outcome.

    Time frame: up to 10 years

  6. Clinical assessment: change from baseline in Strength score

    Grip/grasp, tip and key pinch strength will be evaluated using a dynamometer.

    Time frame: up to 10 years

  7. Clinical assessment: change from baseline in Mobility score

    Evaluation of mobility (movement amplitude and functionality) will be assessed through angle measurement, using a goniometer. Measured movements will be flexion/extension, radial deviation/ulnar deviation, pronation/supination, adduction/abduction, opposition.

    Time frame: up to 10 years

07

Study locations

4 of 4 sites recruiting
  • Clinique du Parc
    Lyon, 69006, France
    • Christophe RIZZO, MD · Contact
    Recruiting
  • Espace Médical Vauban
    Paris, 75007, France
    • Christian COUTURIER, MD · Contact
    Recruiting
  • Institut de la Main Nantes-Atlantique - Pôle Santé-Atlantique
    Saint-Herblain, 44800, France
    • Philippe BELLEMERE, MD · Contact
    Recruiting
  • Orthopedic Surgeon (Dr. med. Dietmar Bignion)
    Bern, 3011, Switzerland
    • BIGNION Dietmar · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04137237
Lead sponsor
Stryker Trauma and Extremities
Responsible party
Sponsor
First posted
Oct 23, 2019
Start date
Nov 14, 2019
Primary completion
Jan 2029 (estimated)
Completion
Jan 2033 (estimated)
Last update
Sep 16, 2025

Study contacts

Amjad Uneisi
Contact
amjad.uneisi@stryker.com
+33638213703
Caryn Thompson
Contact
caryn.thompson@stryker.com
Rebecca Gibson
study director · Stryker Trauma

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion